Dose related effect of Extracorporeal Shock wave therapy for chronic plantar fasciitis between fix and titrate dose: Randomized controlled trial

Phase 2

• Conditions: o exactly method and energy density reflux of ESWT for chronic Plantar fasciitis; Plantar fasciitis; Extracorporeal shockwave therapy : ESWT; Dose efficacy

• Registration Number: TCTR20200505006
• Lead Sponsor: o

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-05
• Study Completion: 2020-12-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

1.age 18 - 60 years old
2.Diagnosed by orthopedist : pain at medial foot when start walking and tender at medial calcalneal tuberosity and symptoms more than 3 months

Exclusion Criteria

1.brain and recognitive impairment
2.Body Mass Index morethan 30 kg/m2
3.Visual Analog Scale (VAS) lessthan 2
4.recieve steriod injection or shockwave within 3 month
5.history of calcaneal fracture or foot and ankle surgery
6.systemic disorders: infection, Gout ,Rheumatoids,bone tumor
7.pregnancy
8.on pacemaker
9. Bleeding disorder: Hemophilia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pain Visual analog score pre and post intervention and between group week 1,2,3 and month 3,6 Numeric rating scale: NRS)

Secondary Outcome Measures

Name	Time	Method
functional score pre and post intervention and between group week 1,2,3 and month 3,6 Visual Analogue Scale foot and ankle : VAS FA